M Rylander

19 papers receiving 363 citations

Peers

M Rylander
Comparison fields: 5 of 64
  • Microbiology 76
  • Molecular Medicine 59
  • Applied Microbiology and Biotechnology 22
  • Clinical Biochemistry 47
  • Endocrine and Autonomic Systems 28
Replace L. G. Burman with:
L. G. Burman Sweden
Valinderjeet Singh Randhawa India
Annemarie Van 't Veen Netherlands
MARTINE DERRIENNIC France
Max Labbe Belgium
Sudarshan Kumari India
Gesit Metaferia Ethiopia
Mikael Sörberg Sweden
Kris P. Heilmann United States
Delores M. Gries United States
M Rylander relative to L. G. Burman Sweden L. G. Burman's profile →
Citations per field
00.5×2×3×4.2×
L. G. Burman · 1×
Citations per year

Countries citing papers authored by M Rylander

Since Specialization
Citations

This map shows the geographic impact of M Rylander's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by M Rylander with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites M Rylander more than expected).

Fields of papers citing papers by M Rylander

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by M Rylander. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by M Rylander. The network helps show where M Rylander may publish in the future.

Co-authors

The 25 scholars most cited alongside M Rylander, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with M Rylander Line = papers co-authored together M Rylander links everyone, so they are left out of the graph.

All Works

19 of 19 papers shown
#Work
1 199869
2 199865
3
In vitro comparison of the activity of doxycycline, tetracycline, erythromycin and a new macrolide, CP 62993, against Mycoplasma pneumoniae, Mycoplasma hominis and Ureaplasma urealyticum.
198844
4 199438
5 199228
6 200026
7 199122
8
Studies on the pharmacokinetics of cefoxitin, cefuroxime, cephaloridine and cephalothin using subcutaneous tissue cages.
197819
9 199119
10 199918
11 200315
12 19839
13 19939
14 19898
15 19957
16 19905
17 19915
18 19991
19 19781

About M Rylander

M Rylander is a scholar working on Clinical Biochemistry, Molecular Medicine, Pharmacology, Infectious Diseases and Endocrine and Autonomic Systems, having authored 19 papers that have together received 408 indexed citations. Recurring topics across this work include Antibiotics Pharmacokinetics and Efficacy (7 papers), Bacterial Identification and Susceptibility Testing (6 papers), Antibiotic Resistance in Bacteria (5 papers), Antimicrobial Resistance in Staphylococcus (4 papers), Neonatal Health and Biochemistry (4 papers), Neonatal Respiratory Health Research (3 papers), Neuroscience of respiration and sleep (3 papers) and Reproductive tract infections research (2 papers). The work is most often cited by research in Microbiology (76 citations), Molecular Medicine (59 citations), Applied Microbiology and Biotechnology (22 citations), Clinical Biochemistry (47 citations) and Endocrine and Autonomic Systems (28 citations). M Rylander has collaborated with scholars based in Sweden, Switzerland and Finland. Frequent co-authors include Gerd Faxelius, Baldvin Jónsson, Hans O. Hallander, Signe Holta Ringertz, Carl Erik Nord, S. Ragnar Norrby, Martin H. Hedberg, LENNART LINDQVIST, Charlotta Edlund and Per G. Montan. Their work appears in journals such as Antimicrobial Agents and Chemotherapy, Acta Paediatrica, European Journal of Clinical Microbiology & Infectious Diseases, Journal of Antimicrobial Chemotherapy and European Journal of Ophthalmology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact